Evidence map›Paper›PMID 35008671›Full record

ReviewInternational journal of molecular sciences2021

Disrupting Neurons and Glial Cells Oneness in the Brain-The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer's Disease.

Matylda Barbara Mielcarska, Katarzyna Skowrońska, Zbigniew Wyżewski, Felix Ngosa Toka

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Antioxidants (Basel, Switzerland) · 2022
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Matylda Barbara MielcarskaDepartment of Preclinical Sciences, Institute of Veterinary Sciences, Warsaw University of Life Sciences-SGGW, Jana Ciszewskiego 8, 02-786 Warsaw, Poland.
Katarzyna SkowrońskaDepartment of Neurotoxicology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Adolfa Pawińskiego 5, 02-106 Warsaw, Poland.ORCID 0000-0002-2612-3186
Zbigniew WyżewskiInstitute of Biological Sciences, Cardinal Stefan Wyszyński University in Warsaw, Dewajtis 5, 01-815 Warsaw, Poland.ORCID 0000-0002-6837-0476
Felix Ngosa TokaDepartment of Preclinical Sciences, Institute of Veterinary Sciences, Warsaw University of Life Sciences-SGGW, Jana Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0001-9560-8665
Warsaw University of Life Sciences · PLCardinal Stefan Wyszynski University in Warsaw · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PL

Funding

National Science Centre Poland UMO-2016/23/N/NZ6/02499
6 · The paper itself

Abstract

Current data strongly suggest herpes simplex virus type 1 (HSV-1) infection in the brain as a contributing factor to Alzheimer's disease (AD). The consequences of HSV-1 brain infection are multilateral, not only are neurons and glial cells damaged, but modifications also occur in their environment, preventing the transmission of signals and fulfillment of homeostatic and immune functions, which can greatly contribute to the development of disease. In this review, we discuss the pathological alterations in the central nervous system (CNS) cells that occur, following HSV-1 infection. We describe the changes in neurons, astrocytes, microglia, and oligodendrocytes related to the production of inflammatory factors, transition of glial cells into a reactive state, oxidative damage, Aβ secretion, tau hyperphosphorylation, apoptosis, and autophagy. Further, HSV-1 infection can affect processes observed during brain aging, and advanced age favors HSV-1 reactivation as well as the entry of the virus into the brain. The host activates pattern recognition receptors (PRRs) for an effective antiviral response during HSV-1 brain infection, which primarily engages type I interferons (IFNs). Future studies regarding the influence of innate immune deficits on AD development, as well as supporting the neuroprotective properties of glial cells, would reveal valuable information on how to harness cytotoxic inflammatory milieu to counter AD initiation and progression.

Indexed as

Alzheimer DiseaseAnimalsBrainHerpesvirus 1, HumanHumansNeurogliaNeuronsOxidative StressAlzheimer’s diseaseastrocytesbrainherpes simplex encephalitisherpes simplex virus type 1 (HSV-1)microgliaoligodendrocytes

Identifiers

PMID35008671
PMCPMC8745046
OpenAlexW4200482634

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.